Ledger.Open graph →
SEC Form D · Amendment · filed May 27, 2015

Bionpharma Inc

Offering
$30.7M
Sold
$30.7M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
PRINCETON, NJ
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Lavesh W. Samtani · Princeton, NJExecDavid W. Goodman · Montreal, Quebec, CanadaDirectorCarol S. Ben-Maimon · Princeton, NJDirectorVenkatachalam Krishnan · Princeton, NJExec · DirectorGaurav W. Mehrotra · Princeton, NJExecJames E. Gale · New York, NYDirectorRichard W. Van Duyne · Princeton, NJDirectorDavid B. Iben · Tampa, FLDirectorJames Warner · San Francisco, CAExecDavid M. Fang · Dallas, TXDirectorBryan Larson · Dallas, TXExec · DirectorBrian W. Pickering · Rochester, MNExecNeda B. Yarich · Tampa, FLDirectorMichael Wystrach · Tempe, AZDirectorIan Rosen · Brooklyn, NYExecDamian Juric · Grand Cayman, Cayman IslandsExec · DirectorTammy Jennissen · Grand Cayman, Cayman IslandsDirectorThierry Bernard · Cambridge, MAExec · DirectorIsabel B. Satra · Tampa, FLDirectorJeffrey S. Jacob · STAMFORD, CTDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗